KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,143,588 | +26.7% | 296,119 | +2.7% | 0.00% | 0.0% |
Q2 2023 | $4,058,941 | +29.1% | 288,277 | -1.3% | 0.00% | 0.0% |
Q1 2023 | $3,143,211 | -26.8% | 292,120 | +1.9% | 0.00% | 0.0% |
Q4 2022 | $4,294,392 | +23.2% | 286,675 | +5.6% | 0.00% | 0.0% |
Q3 2022 | $3,486,000 | +30.7% | 271,434 | -1.4% | 0.00% | 0.0% |
Q2 2022 | $2,667,000 | +0.1% | 275,305 | +2.7% | 0.00% | – |
Q1 2022 | $2,664,000 | -19.3% | 268,045 | -4.5% | 0.00% | -100.0% |
Q4 2021 | $3,303,000 | +5.6% | 280,632 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $3,127,000 | -21.6% | 274,558 | -4.1% | 0.00% | 0.0% |
Q2 2021 | $3,986,000 | -28.1% | 286,198 | -4.4% | 0.00% | 0.0% |
Q1 2021 | $5,540,000 | +0.2% | 299,315 | -4.4% | 0.00% | 0.0% |
Q4 2020 | $5,531,000 | +14.8% | 313,002 | -0.4% | 0.00% | 0.0% |
Q3 2020 | $4,817,000 | -20.2% | 314,412 | +32.7% | 0.00% | 0.0% |
Q2 2020 | $6,039,000 | +121.5% | 237,010 | +34.5% | 0.00% | 0.0% |
Q1 2020 | $2,727,000 | +66.4% | 176,216 | +18.9% | 0.00% | – |
Q4 2019 | $1,639,000 | +17.8% | 148,208 | -9.4% | 0.00% | – |
Q3 2019 | $1,391,000 | -33.7% | 163,513 | +5.6% | 0.00% | – |
Q2 2019 | $2,097,000 | -12.2% | 154,899 | +17.1% | 0.00% | -100.0% |
Q1 2019 | $2,389,000 | +8.2% | 132,254 | +68.3% | 0.00% | 0.0% |
Q4 2018 | $2,207,000 | +9.6% | 78,584 | -0.5% | 0.00% | – |
Q3 2018 | $2,013,000 | – | 78,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |